Indication
Prevention of recurrent atrial fibrillation
The prevention of recurrent atrial fibrillation refers to the long-term maintenance of normal sinus rhythm in patients who have experienced two or more documented episodes of this supraventricular tachyarrhythmia, including paroxysmal or persistent forms. Read more about Prevention of recurrent atrial fibrillation
118 drugs 75 manufacturers
Drugs that treat it
Common Prevention of recurrent atrial fibrillation therapies.
SOTALOL (sotalol HCl)
SOTALOL (sotalol HCl)
SOTALOL AF (sotalol HCl)
QUINIDINE GLUCONATE
DOFETILIDE
DOFETILIDE
FLECAINIDE ACETATE
FLECAINIDE ACETATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThe prevention of recurrent atrial fibrillation refers to the long-term maintenance of normal sinus rhythm in patients who have experienced two or more documented episodes of this supraventricular tachyarrhythmia, including paroxysmal or persistent forms.
Affecting the cardiac conduction system, the condition is pathophysiologically characterized by disorganized atrial electrical activity—frequently triggered by ectopic foci within the pulmonary veins—accompanied by structural remodeling, fibrosis, and impaired atrial mechanical contraction.
These recurrences lead to an irregular, often rapid ventricular response, producing symptoms such as palpitations, fatigue, and dyspnea while significantly elevating the risks of thromboembolic stroke and heart failure.
- nih.gov
The prevention of recurrent atrial fibrillation refers to the long-term maintenance of normal sinus rhythm in patients who have experienced two or more documented episodes of this supraventricular tachyarrhythmia, including paroxysmal or persistent forms
- e-jcpp.org
The prevention of recurrent atrial fibrillation refers to the long-term maintenance of normal sinus rhythm in patients who have experienced two or more documented episodes of this supraventricular tachyarrhythmia, including paroxysmal or persistent forms
- pharmacytimes.com
Affecting the cardiac conduction system, the condition is pathophysiologically characterized by disorganized atrial electrical activity—frequently triggered by ectopic foci within the pulmonary veins—accompanied by structural remodeling, fibrosis, and impaired atrial mechanical contraction These recurrences lead to an irregular, often rapid ventricular response, producing symptoms such as palpitations, fatigue, and dyspnea while significantly elevating the risks of thromboembolic stroke and hear...
- hopkinsmedicine.org
Affecting the cardiac conduction system, the condition is pathophysiologically characterized by disorganized atrial electrical activity—frequently triggered by ectopic foci within the pulmonary veins—accompanied by structural remodeling, fibrosis, and impaired atrial mechanical contraction These recurrences lead to an irregular, often rapid ventricular response, producing symptoms such as palpitations, fatigue, and dyspnea while significantly elevating the risks of thromboembolic stroke and hear...
- nih.gov
These recurrences lead to an irregular, often rapid ventricular response, producing symptoms such as palpitations, fatigue, and dyspnea while significantly elevating the risks of thromboembolic stroke and heart failure
Personalize your experience
Follow Prevention of recurrent atrial fibrillation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.